Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07092774 · ClinicalTrials.gov registry record
Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)
A clinical trial of Paroxysmal Atrial Fibrillation (PAF), sponsored by Heart Rhythm Clinical and Research Solutions.
- Active
- Registry status
- 344
- Enrollment target
- 12
- Study locations
NCT07092774 is a study of Paroxysmal Atrial Fibrillation (PAF) that is active but no longer recruiting, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 344 participants. The trial reports 12 study locations across 10 states.
The verdict
NCT07092774, a study of Paroxysmal Atrial Fibrillation (PAF), is active but no longer recruiting, sponsored by Heart Rhythm Clinical and Research Solutions.
- ACTIVE NOT RECRUITING
- Registry status
- 344 participants
- Enrollment target
- 12
- Study locations
Study Summary
To generate real-world evidence from the parent study, REAL AF registry, on the use of Thermocool SmartTouch SF (STSF) catheter in ablation for the treatment of paroxysmal atrial fibrillation (PAF).
Conditions Studied
Interventions
- DEVICE Ablation
Study Locations (12)
Florida
- Ascension St. Vincent's - Jacksonville
- Sarasota Memorial Hospital - Sarasota
Pennsylvania
- University of Pennsylvania, Penn Presbyterian Medical Center - Philadelphia
- Allegheny Health Network - Pittsburgh
Alabama
- Arrhythmia Institute at Grandview - Birmingham
California
- Community Memorial Hospital - Ventura
Illinois
- Northshore University Health System - Evanston
Indiana
- Ascension St. Vincent's Hospital - Indianapolis
Michigan
- Michigan Heart - Ypsilanti
Ohio
- Mount Carmel Columbus Cardiology Consultants - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07092774
The ClinicalTrials.gov registry entry for NCT07092774 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heart Rhythm Clinical and Research Solutions, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paroxysmal Atrial Fibrillation (PAF) appearing as the primary indexed condition, and to 1 intervention - of which Ablation is the first listed.
NCT07092774 reports 12 study locations spanning 10 distinct geographic areas - top geographies include Florida, Pennsylvania, Alabama.
Frequently Asked Questions
What is clinical trial NCT07092774 about?
NCT07092774 is a clinical study titled "Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)". To generate real-world evidence from the parent study, REAL AF registry, on the use of Thermocool SmartTouch SF (STSF) catheter in ablation for the treatment of paroxysmal atrial fibrillation (PAF).
What is the current status of trial NCT07092774?
This trial is currently active not recruiting. The enrollment target is 344 participants. The study started on 2024-04-01. Estimated completion is 2025-12.
What conditions does trial NCT07092774 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation (PAF).
What interventions are being tested in trial NCT07092774?
The interventions under investigation include: Ablation (DEVICE).
Who is sponsoring clinical trial NCT07092774?
This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07092774 being conducted?
This trial has 12 study locations across Alabama, California, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation (PAF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.